走进诺和诺德 更多 >>
诺和诺德是一家致力于人类健康、以先进的生物技术造福患者、医生和社会的世界领先生物制药公司。
诺和诺德公司的历史最早可追溯至1923年，80多年来一直是世界糖尿病研究和药物开发领域的主导。诺和诺德总部位于丹麦首都哥本哈根，现在全球79个国家设有分支机构，6个国家设有生产厂，截至08年底，员工超过 27，000名，销售遍及180个国家。
诺和诺德凭借自身的研发实力成为世界糖尿病治疗领域先导，在行业内拥有最为广泛的糖尿病治疗产品，其中包括最先进的胰岛素给药系统产品。
北京中日友好医院杨文英教授
Yang Wenying
Beijing, China
Yang Wenying is a Supervisor of Ph.D. candidates. She is currently the Director of the Department of Endocrinology at the China-Japan Friendship Hospital and holds a number of concurrent positions, including Chairperson of the diabetes branch of the Chinese Medical Association. She is a member of Editorial Committees for several journals as well as a member of many Review Committees.
Professor Yang has led and participated in numerous Ministry of Health and national projects, such as diabetes research in Daqing region. She led the morbidity and prevalence investigation in 1994 and 2007 and relevant factors analysis of diabetes and metabolic syndrome in China. She has been involved in several national multicenter prospective clinical studies. In the area of pre-clinical studies, she was the first in China to investigate the role of lipid toxicity in the pathogenesis of diabetes.
Professor Yang has published nearly 200 papers in national and international core journals and has won several Awards of Science and Technology Achievements.
编辑: xiaoyan 作者:丁香园通讯员
以下网友留言只代表网友个人观点，不代表网站观点
